Accueil / Tag Archives: New-York (page 21)

Tag Archives: New-York

Sesen Bio to Present at the H.C. Wainwright 21st Annual Global Investment Conference

Tuesday, September 3rd 2019 at 11:00am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced it will be featured as a presenting company at the H.C. Wainwright 21st Annual Global Investment Conference on …

Plus »

Poxel Announces Participation at the H.C. Wainwright 21st Annual Global Investment Conference

Wednesday, September 4th 2019 at 3:45pm UTC LYON, France–(BUSINESS WIRE)– POXEL S.A. (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), announced today that it will be featured as a presenting company at …

Plus »

Qosina Carries a New Line of Securing Clamps for High-Pressure Connections

Wednesday, September 4th 2019 at 3:01pm UTC RONKONKOMA, N.Y.–(BUSINESS WIRE)– Qosina is pleased to stock a variety of Oetiker® stainless steel, non-greased StepLess® ear clamps that can be used in a wide range of applications across multiple industries. These clamps are ideal for high-pressure connections where leakage is a concern, …

Plus »

Puma Biotechnology to Present at the H.C. Wainwright 21st Annual Global Investment Conference

Tuesday, September 3rd 2019 at 8:25pm UTC LOS ANGELES–(BUSINESS WIRE)– Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 9:35 a.m. EDT on Tuesday, September 10, at the H.C. …

Plus »

Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in September

Tuesday, September 3rd 2019 at 11:00am UTC HENDERSON, Nev.–(BUSINESS WIRE)– Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, announced today that an overview of the company’s business strategy and development-stage programs will be given at two upcoming conferences being held in New York on …

Plus »

Rocket Pharmaceuticals Announces First Patient Treated in Phase 1/2 Registrational Trial of RP-L201 for LAD-I

Thursday, September 5th 2019 at 11:00am UTC – Preliminary Phase 1 Data Expected by the End of 2019 – NEW YORK–(BUSINESS WIRE)– Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform clinical-stage gene therapy company, today announces that the first patient received investigational therapy in the open-label, Phase 1/2 …

Plus »

Hologic to Webcast Presentation at the Morgan Stanley 17th Annual Global Healthcare Conference

Wednesday, September 4th 2019 at 8:02pm UTC MARLBOROUGH, Mass.–(BUSINESS WIRE)– Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Morgan Stanley 17th Annual Global Healthcare Conference in New York, NY on Tuesday, September 10 at 12:20 p.m. Eastern Time. The presentation will be webcast live and …

Plus »

Tetraphase Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

Tuesday, September 3rd 2019 at 12:00pm UTC WATERTOWN, Mass–(BUSINESS WIRE)– Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline XERAVATM (eravacycline for injection) to treat serious and life-threatening infections, today announced that senior management will present a corporate overview at the H. C. Wainwright and Company …

Plus »

Teva to Present New Analyses of Fremanezumab Efficacy and Safety in Adult Patients with Difficult-to-Treat Migraine at 19th Congress of the International Headache Society

Wednesday, September 4th 2019 at 8:14pm UTC Late breaking data examines 10-year cost effectiveness of fremanezumab, while one oral presentation and 29 posters highlight FOCUS Phase IIIb study data in adult patients with migraine and documented inadequate response to 2-4 classes of prior preventive treatments, along with patient survey results …

Plus »

Masimo to Present at Morgan Stanley 17th Annual Global Healthcare Conference

Wednesday, September 4th 2019 at 1:00pm UTC IRVINE, Calif.–(BUSINESS WIRE)– Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Morgan Stanley 17th Annual Global Healthcare Conference at the Grand Hyatt New York on Tuesday, September 10, 2019 at 3:30 p.m. Eastern Time. A live audiocast …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.